ARCHIVES

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

This article is from The Cancer Letter archive.

Vol. 21 No. 18 | May 5, 1995

Download PDF Visit The Full Archive

Related Articles

Wyden Plans Bill To Induce Drug Firms to conduct Trials

October 29, 1993

NCI’s Richard Kaplan named associate director, National Cancer Research Network of UK.

January 2, 2004

NCI Publishes New Atlas Of Cancer Mortality

December 10, 1999

Funding Opportunities.

June 28, 2002

After a “humble” start at NCI, von Eschenbach set unachievable goal.

September 30, 2005

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

October 21, 2005